Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Evaluation of a Novel Bimodal-Approach Radiofrequency Device for Lower Facial Tightening in Southeast Asian Patients: An Open-Label Prospective Study.

Journal of cosmetic dermatology·2026
Same journal

Global Publication Trends and Advances in Striae Distensae Research: A Bibliometric Analysis.

Journal of cosmetic dermatology·2026
Same journal

Supraumbillical Skin Retraction After Laser Assisted Liposuction/Lipolysis.

Journal of cosmetic dermatology·2026
Same journal

Chlorella Polysaccharide Extract Attenuates Skin Aging via MAPK Pathway Suppression: Implications for Cosmetic Dermatology.

Journal of cosmetic dermatology·2026
Same journal

Similarities and Differences in the Perception of Artificially Modified Faces Between Caucasian and Chinese Observers.

Journal of cosmetic dermatology·2026
Same journal

Evaluation of Tissue Response to Coinjection Versus Individual Injection of Hyaluronic Acid Filler and Polycaprolactone Microsphere-Based Filler in a Rabbit Model.

Journal of cosmetic dermatology·2026

Related Experiment Video

Updated: Jun 6, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Exogenous ochronosis--a diagnostic challenge.

Siak-Khim Tan

    Journal of Cosmetic Dermatology
    |December 3, 2010
    PubMed
    Summary

    Exogenous ochronosis, a skin condition from long-term use of skin-lightening creams, presents diagnostic challenges. This report details six diverse cases in Singapore, highlighting varying facial dyschromias.

    Area of Science:

    • Dermatology
    • Toxicology

    Background:

    • Exogenous ochronosis is a rare, often iatrogenic, skin condition linked to prolonged topical application of depigmenting agents.
    • Hydroquinone, phenol, and resorcinol are common causative agents found in skin-lightening products, leading to ochronosis.
    • The condition is characterized by a distinctive blue-black or brownish-grey hyperpigmentation, often on sun-exposed areas.

    Observation:

    • This report focuses on six patients presenting with exogenous ochronosis in Singapore.
    • The patients exhibited significant variability in their facial dyschromias, complicating initial diagnosis.
    • Clinical presentation ranged from subtle pigmentary changes to more pronounced reticular or nodular patterns.

    Findings:

    • The study highlights the diverse clinical manifestations of exogenous ochronosis, even with similar causative agents.

    More Related Videos

    Improved Lipofuscin Models and Quantification of Outer Segment Phagocytosis Capacity in Highly Polarized Human Retinal Pigment Epithelial Cultures
    10:39

    Improved Lipofuscin Models and Quantification of Outer Segment Phagocytosis Capacity in Highly Polarized Human Retinal Pigment Epithelial Cultures

    Published on: April 14, 2023

    Related Experiment Videos

    Last Updated: Jun 6, 2026

    Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
    10:14

    Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

    Published on: May 26, 2023

    Improved Lipofuscin Models and Quantification of Outer Segment Phagocytosis Capacity in Highly Polarized Human Retinal Pigment Epithelial Cultures
    10:39

    Improved Lipofuscin Models and Quantification of Outer Segment Phagocytosis Capacity in Highly Polarized Human Retinal Pigment Epithelial Cultures

    Published on: April 14, 2023

  • Diagnostic difficulties arise due to the varied presentation and potential overlap with other pigmentary disorders.
  • Long-term use of skin-lightening creams containing hydroquinone, phenol, or resorcinol was the common etiology.
  • Implications:

    • Increased awareness among clinicians regarding the varied presentation of exogenous ochronosis is crucial for timely diagnosis.
    • Dermatologists should consider exogenous ochronosis in patients with unexplained facial dyschromias, especially with a history of using skin-lightening products.
    • This underscores the importance of monitoring and regulating the use of potent depigmenting agents in cosmetic products.